[go: up one dir, main page]

TWI403581B - - Google Patents

Info

Publication number
TWI403581B
TWI403581B TW099104629A TW99104629A TWI403581B TW I403581 B TWI403581 B TW I403581B TW 099104629 A TW099104629 A TW 099104629A TW 99104629 A TW99104629 A TW 99104629A TW I403581 B TWI403581 B TW I403581B
Authority
TW
Taiwan
Prior art keywords
immune killer
culture
immune
killer cells
killer cell
Prior art date
Application number
TW099104629A
Other languages
English (en)
Other versions
TW201127959A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to TW099104629A priority Critical patent/TW201127959A/zh
Priority to US13/024,087 priority patent/US9222072B2/en
Publication of TW201127959A publication Critical patent/TW201127959A/zh
Application granted granted Critical
Publication of TWI403581B publication Critical patent/TWI403581B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW099104629A 2010-02-12 2010-02-12 Method of producing immune killer cell TW201127959A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW099104629A TW201127959A (en) 2010-02-12 2010-02-12 Method of producing immune killer cell
US13/024,087 US9222072B2 (en) 2010-02-12 2011-02-09 Manufacturing method of immune killer cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW099104629A TW201127959A (en) 2010-02-12 2010-02-12 Method of producing immune killer cell

Publications (2)

Publication Number Publication Date
TW201127959A TW201127959A (en) 2011-08-16
TWI403581B true TWI403581B (zh) 2013-08-01

Family

ID=44369914

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099104629A TW201127959A (en) 2010-02-12 2010-02-12 Method of producing immune killer cell

Country Status (2)

Country Link
US (1) US9222072B2 (zh)
TW (1) TW201127959A (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3746095A4 (en) 2018-02-01 2021-04-21 Nkmax Co., Ltd. Method of producing natural killer cells and composition for treating cancer
CN111019892A (zh) * 2019-12-16 2020-04-17 杭州恩格生物医疗科技有限公司 一种免疫细胞体外诱导扩增方法
CN112251405A (zh) * 2020-10-15 2021-01-22 大连天星生物技术有限责任公司 一种体外高效诱导扩增nk细胞的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101314764A (zh) * 2008-06-24 2008-12-03 蚌埠医学院 一种体外扩增自然杀伤细胞的方法
CN101495620A (zh) * 2006-08-01 2009-07-29 阿利健制药有限公司 Lak细胞的增殖方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068306A1 (en) * 2001-09-14 2003-04-10 Dilber Mehmet Sirac Medium
CN1245504C (zh) 2003-12-19 2006-03-15 上海伯瑞生物技术发展有限公司 一种cik细胞体外培养方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495620A (zh) * 2006-08-01 2009-07-29 阿利健制药有限公司 Lak细胞的增殖方法
CN101314764A (zh) * 2008-06-24 2008-12-03 蚌埠医学院 一种体外扩增自然杀伤细胞的方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Nair et al., Immunoregulation of natural and lymphokine-activated killer cells by selenium. Immunopharmacology, 19 (1990) 177-183. *

Also Published As

Publication number Publication date
TW201127959A (en) 2011-08-16
US9222072B2 (en) 2015-12-29
US20110201114A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
EA201270173A1 (ru) Получение полиовируса с высокими титрами для получения вакцины
MX2020006117A (es) Integracion dirigida de acidos nucleicos.
EP4275760A3 (en) Egg protein formulations and methods of manufacture thereof
EA201590488A1 (ru) Способы модификации клеток-хозяев
EA201991976A1 (ru) Метаболически оптимизированная клеточная культура
PH12015500284A1 (en) Interleukin-10 fusion proteins and uses thereof
WO2012062810A3 (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
EA201492057A1 (ru) Ферментация и способ с псевдодвижущимся слоем
BR112015013525A2 (pt) método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão
MY181688A (en) Improved production of fatty acid derivatives
MX355501B (es) Estructuras de consenso de antigenos y vacunas elaboradas a partir de estas y metodos para utilizarlas en el tratamiento de la malaria.
MX351565B (es) Colageno 7 y metodos relacionados.
EA201290813A1 (ru) Полиэпитопные конструкции и способы их получения и применения
PH12013502600A1 (en) Rabies virus like particle production in plants
IN2014CN03077A (zh)
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
MX387420B (es) Producción de virus en cultivos celulares.
EA201400216A1 (ru) Консервирование биологических продуктов, в частности вакцин, с применением вакуума
MX373329B (es) Células eucariotas novedosas y métodos para la expresión recombinante de un producto de interés.
MX2013013228A (es) Particulas similares a virus y proceso para prepararlas.
EA201400192A1 (ru) Клетка, ферментирующая пентозы
EA201891335A1 (ru) Добавление аргинина с целью повышения эффективности ацетогенов, ферментирующих газ
IN2014DN06660A (zh)
WO2013162905A8 (en) Methods of producing and using regulatory b-cells